🟢 Inovio Pharmaceuticals is trading 6% up — no clear catalyst identified

Inovio Pharmaceuticals is trading 5.98% higher at $1.04, with no clear company-specific catalyst identified.

• The broader biotech sector is higher, with XBI up 2.20%; the supplied market snapshot is mixed, not a broad-market rally.
• October 15 coverage reported AstraZeneca had narrowed its long-standing collaboration with the company, a negative development that does not explain the gain.